FDA: Commissioner Gottlieb Kratom Communications

Anthony Roberts filed this request with the Food and Drug Administration of the United States of America.
Tracking #

2017-9719

Due Dec. 13, 2017
Est. Completion None
Status
Awaiting Response

Communications

From: Anthony Roberts

To Whom It May Concern:

This is a request under the Freedom of Information Act. I hereby request all communications made to, from, or by, FDA commissioner Scott Gottlieb, in regards to kratom. This should include but not be limited to emails, memorandum, and records of same (i.e. meetings held, seminars attended , etc...)

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

anthony roberts

From: Food and Drug Administration

An acknowledgement letter, stating the request is being processed.

From: Food and Drug Administration

Dear Mr. Roberts,

I have received the records for your request. I will conduct my review of the upon my return to the office in early January.

You may contact me directly with any further concerns regarding your request.

Sincerely,

Celeste Smith
Government Information Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8991
celeste.smith@fda.hhs.gov<mailto:celeste.smith@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

From: Anthony Roberts

Thanks, I appreciate your attention and promptness on this request. As you're likely aware, this is a matter that concerns millions of Americans, many of whom have expressed a desire to see these documents, as they relate to potential scheduling that would have a direct effect on them.

From: Food and Drug Administration

Mr. Roberts, the records are currently being reviewing. You should check with me again in a few weeks.

From: Anthony Roberts

Thank you. I'll check back next month.

From: Anthony Roberts

Hello-

I'm just checking in on the records being reviewed for FOIA 2017-9719 (a MuckRock freedom of Information Request on Commissioner Gottlieb's Kratom Communications) per your last email. Are they out of review and are you able to send them to us?

~Anthony Roberts

From: Food and Drug Administration

Good morning. I have completed my review of the records. The records have been forwarded on for a second review prior to release. I apologize, I cannot provide an estimate of time for how long it will take for the reviewer to complete their review. As soon as the review is complete, you will receive our response.

Celeste

From: Food and Drug Administration

Good morning. We are currently reviewing these records for release.

Thanks,

Sarah B. Kotler, J.D.
Director
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8976
Sarah.Kotler@fda.hhs.gov<mailto:Sarah.Kotler@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

[cid:image002.jpg@01D1C57E.DFA022A0]<https://www.facebook.com/FDA> [cid:image003.jpg@01D1C57E.DFA022A0] <https://twitter.com/US_FDA> [cid:image004.jpg@01D1C57E.DFA022A0] <http://www.youtube.com/user/USFoodandDrugAdmin> [cid:image005.jpg@01D1C57E.DFA022A0] <http://www.flickr.com/photos/fdaphotos/> [cid:image006.jpg@01D1C57E.DFA022A0] <http://www.fda.gov/AboutFDA/ContactFDA/StayInformed/RSSFeeds/default.htm>

From: Food and Drug Administration

Good morning. Your request is still under review.
Thanks,

Celeste Smith
Government Information Specialist
Office of the Executive Secretariat
Division of Freedom of Information
U.S. Food and Drug Administration
Tel: 301-796-8991
celeste.smith@fda.hhs.gov<mailto:celeste.smith@fda.hhs.gov>

[cid:image001.png@01D1C57E.DFA022A0]<http://www.fda.gov/>

Files

pages

Close